Purchase Order 75F40121P00309
Award Date 7/5/21
Potential Completion Date 7/5/22
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) awarded a $75,000.00 firm fixed-price definitive contract to Multicase, Inc. for the licensing and maintenance of the CASE ULTRA and META ULTRA toxicology modeling software. This software aids in assessing the potential of chemicals and pharmaceuticals. The contract has an ultimate completion date of July 29, 2028 and does not have a set-aside designation. Multicase, Inc. is the prime contractor and has previously provided the CASE ULTRA and META ULTRA...
- This is a $165,457 firm-fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a for-profit limited liability company. The contract is for the delivery of mechanistic chromatography modeling software. This award is not associated with a set-aside program. Through this contract, the FDA is acquiring scientific software to support its biomedical research and laboratory operations. Global Life Sciences Solutions USA LLC is...
- The U.S. Food and Drug Administration (FDA) awarded a $13,992 firm fixed-price purchase order to Comsol, Inc. for multiphysics computational fluid dynamics modeling software. The contract, awarded on August 28, 2025, is set to conclude by September 1, 2026, with performance taking place at the FDA's facility in Rockville, Maryland. This award represents a straightforward commercial off-the-shelf software acquisition with no small business set-aside designation. Comsol, Inc., headquartered in...
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Accessagility LLC, a small business IT solutions provider based in Vienna, Virginia. The contract, valued at $35,449.50, is for the provision of MULTICASE software. The contract does not have a set-aside designation. Accessagility has a strong track record of supporting federal agencies with a range of IT products and services, including software licenses, maintenance,...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...
- This is a $845,852.26 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Certara USA Inc. for the licensing of the company's CDER CERTARA PHOENIX software products. The award is not associated with a set-aside program and is intended to provide the FDA's Office of Clinical Pharmacology with necessary software tools, including Phoenix WinNonlin, NLME, IVIVC, Connect, and Trial Simulator, to support the review of Investigational New Drug (IND), New Drug...
- This is a $140,000.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Altamira, LLC, a minority-owned and woman-owned small business. The contract provides a software license and maintenance support for the Chem Tunes ToxGPS platform, which assists with chemical data management, virtual liver modeling, and toxicity prediction to support the FDA's environmental protection and drug development mission. Altamira, a prime contractor without major...
- The Food and Drug Administration awarded a $169.5K firm fixed-price purchase order to Certara USA Inc. for annual named user server licenses of Phoenix WinNonlin, Phoenix Connect, Phoenix NLME, and unlimited server license for distributed computing. The award was issued on July 30, 2019, with performance to be completed by July 29, 2022, at the contractor's facility in Silver Spring, Maryland. This contract was not set-aside and followed a solicitation posted on July 18, 2019, with award...
- The Food and Drug Administration (FDA) awarded a $2,374,057 firm-fixed-price purchase order contract to Pragmatic Data LLC, a small disadvantaged business, for software licenses, maintenance, and professional services. This contract supports various FDA programs and covers a range of capabilities, including data integration, data standard enhancements, and support for the FDA's regulatory and compliance missions. Additionally, Pragmatic Data has received other contracts from the FDA to provide...